ecrin-mdr-crcClinical2020IPD Sharing (as of January 2020): UndecidedHER-2 Positive Colorectal CancerColorectal NeoplasmsHer-2 Positive Colorectal CancerColorectal NeoplasmsInterventionalhttps://newmdr.ecrin.org/Study/2326840China1CapecitabineECRIN MDRNot providedfalseA Study of Pyrotinib Combined With Capecitabine for Metastatic HER-2 Positive Colorectal CancerTo evaluate the efficacy and safety of pyrotinib combined with capecitabine in patients with metastatic her-2 positive colorectal cancer after standard treatment.2020-01-152326840NCT04227041